Works matching IS 02698811 AND DT 2015 AND VI 29 AND IP 5
Results: 14
Effects of 10 to 30 years of lithium treatment on kidney function.
- Published in:
- Journal of Psychopharmacology, 2015, v. 29, n. 5, p. 608, doi. 10.1177/0269881115573808
- By:
- Publication type:
- Article
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.
- Published in:
- Journal of Psychopharmacology, 2015, v. 29, n. 5, p. 459, doi. 10.1177/0269881115581093
- By:
- Publication type:
- Article
Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial.
- Published in:
- Journal of Psychopharmacology, 2015, v. 29, n. 5, p. 575, doi. 10.1177/0269881115578160
- By:
- Publication type:
- Article
Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
- Published in:
- Journal of Psychopharmacology, 2015, v. 29, n. 5, p. 623, doi. 10.1177/0269881115578159
- By:
- Publication type:
- Article
Tianeptine in an experimental medicine model of antidepressant action.
- Published in:
- Journal of Psychopharmacology, 2015, v. 29, n. 5, p. 582, doi. 10.1177/0269881115573810
- By:
- Publication type:
- Article
Antidepressants and the adolescent brain.
- Published in:
- Journal of Psychopharmacology, 2015, v. 29, n. 5, p. 545, doi. 10.1177/0269881115573542
- By:
- Publication type:
- Article
Early effects of duloxetine on emotion recognition in healthy volunteers.
- Published in:
- Journal of Psychopharmacology, 2015, v. 29, n. 5, p. 634, doi. 10.1177/0269881115570085
- By:
- Publication type:
- Article
Neural correlates of change in major depressive disorder anhedonia following open-label ketamine.
- Published in:
- Journal of Psychopharmacology, 2015, v. 29, n. 5, p. 596, doi. 10.1177/0269881114568041
- By:
- Publication type:
- Article
Association of ARRB1 polymorphisms with the risk of major depressive disorder and with treatment response to mirtazapine.
- Published in:
- Journal of Psychopharmacology, 2015, v. 29, n. 5, p. 615, doi. 10.1177/0269881114554273
- By:
- Publication type:
- Article
Antidepressant drug development: Focus on triple monoamine reuptake inhibition.
- Published in:
- Journal of Psychopharmacology, 2015, v. 29, n. 5, p. 526, doi. 10.1177/0269881114553252
- By:
- Publication type:
- Article
Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population.
- Published in:
- Journal of Psychopharmacology, 2015, v. 29, n. 5, p. 642, doi. 10.1177/0269881114552744
- By:
- Publication type:
- Article
Analysis of potentially predictive factors of efficacy of adjunct extended-release quetiapine fumarate in patients with major depressive disorder.
- Published in:
- Journal of Psychopharmacology, 2015, v. 29, n. 5, p. 565, doi. 10.1177/0269881114552715
- By:
- Publication type:
- Article
Hippocampal volume and the rapid antidepressant effect of ketamine.
- Published in:
- Journal of Psychopharmacology, 2015, v. 29, n. 5, p. 591, doi. 10.1177/0269881114544776
- By:
- Publication type:
- Article
Fixed dose-combination products in psychiatry: Systematic review and meta-analysis.
- Published in:
- Journal of Psychopharmacology, 2015, v. 29, n. 5, p. 556, doi. 10.1177/0269881114541016
- By:
- Publication type:
- Article